13 insiders reported 14 Form 4 transactions for Traws Pharma, Inc. (TRAW) over the past 18 months (most recent 2026-04-28). Recent activity: ORBIMED ADVISORS LLC (10% Owner) Buy 597,729 shares, OrbiMed Capital GP VIII LLC (10% Owner) Buy 597,729 shares, Parker Charles Nolan (Chief Financial Officer) Buy 15,393 shares, Dukes Iain D. (Chief Executive Officer) Buy 36,943 shares, Shoemaker Mary Teresa (Director) Buy 6,157 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-28 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 597,729 | $998,207 |
| 2026-04-28 | OrbiMed Capital GP VIII LLC | 10% Owner | Buy | 597,729 | $998,207 |
| 2026-04-08 | Parker Charles Nolan | Chief Financial Officer | Buy | 15,393 | $0 |
| 2025-12-16 | Dukes Iain D. | Chief Executive Officer | Buy | 36,943 | $0 |
| 2025-12-16 | Shoemaker Mary Teresa | Director | Buy | 6,157 | $0 |
| 2025-12-16 | CAUTREELS WERNER | Director | Buy | 4,874 | $0 |
| 2025-12-16 | Clarke Trafford | Director | Buy | 6,157 | $0 |
| 2025-12-16 | Redfield Robert | Chief Medical Officer | Buy | 16,419 | $0 |
| 2025-12-16 | Pauza Charles David | Chief Science Officer Virology | Buy | 18,471 | $0 |
| 2025-12-16 | STOVER JACK E | Director | Buy | 6,157 | $0 |
| 2025-12-16 | Leaman John Harold | Director | Buy | 4,058 | $0 |
| 2025-12-16 | Savchuk Nikolay | Chief Operating Officer | Buy | 16,419 | $0 |
| 2025-04-08 | TPAV, LLC | Insider | Sell | 605,531 | $0 |
| 2025-04-08 | Savchuk Nikolay | Chief Operating Officer | Sell | 605,531 | $0 |
Source: SEC Form 4 filings · as of 2026-04-28